Toronto Dominion Bank
EPRX

Toronto Dominion Bank’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Toronto Dominion Bank’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$237K Buy
+32,898
New +$265K ﹤0.01% 1551
2024
Q3 		– Sell
-118
Closed -$304 – 1467
2024
Q2 		$304 Buy
+118
New +$328 ﹤0.01% 1291

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Toronto Dominion Bank's EPRX Position: Q1 2026 in Review

Toronto Dominion Bank opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q1 2026: 32,898 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #1551 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in EPRX as recently as Q2 2024.

Toronto Dominion Bank first reported a position in EPRX in Q2 2024 and has held it in 2 quarters since. 54 funds tracked by Wall St. Rank hold EPRX as of Q1 2026.

  • Toronto Dominion Bank held 32,898 shares of Eupraxia Pharmaceuticals worth $237K as of Q1 2026.
  • Eupraxia Pharmaceuticals was a new Toronto Dominion Bank position in Q1 2026.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1551 holding.
  • Toronto Dominion Bank first reported a position in Eupraxia Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 54 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.